AKAN Stock Analysis: Buy, Sell, or Hold?
AKAN - Akanda Corp. Common Shares
$0.62
0.02 (2.85%)
▲
5d:
-22.99%
30d:
-37.25%
90d:
+29.58%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: Apr 29, 2026
28d
Get Alerted When AKAN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AKAN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: AKAN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: AKAN is currently trading at $0.62, which is considered oversold relative to its 30-day fair value range of $0.79 to $0.94.
Technical Outlook: Technically, AKAN is showing sideways momentum. Immediate support is located at $0.51, while resistance sits at $0.88.
Market Sentiment: AKAN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AKAN is showing sideways momentum. Immediate support is located at $0.51, while resistance sits at $0.88.
Market Sentiment: AKAN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.79 -
$0.94
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
52.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- CAUTION: 5-day price weakness (-23.0%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$0.79 -
$0.94
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.51
Resistance Level
$0.88
Current Trend
Sideways
Technical data as of
Mar 30, 2026
Fundamental Context
Revenue Growth (YoY)
21.9%
Profit Margin
-266.3%
Share & Embed Analysis
Last updated: March 31, 2026 10:07 AM ET
Data refreshes hourly during market hours. Next update: 11:07 AM
Data refreshes hourly during market hours. Next update: 11:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AKAN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$178 | 63 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$151 | 55 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$91 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 63 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 56 HOLD |
